Rchr
J-GLOBAL ID:201301010431920553   Update date: Nov. 03, 2024

Masaaki Korenaga

コレナガ マサアキ | Masaaki Korenaga
Affiliation and department:
Homepage URL  (1): http://kaken.nii.ac.jp/d/r/70420536.ja.html
Research field  (1): Gastroenterology
Research keywords  (24): 小胞体ストレス ,  酸化ストレス ,  ミトコンドリア ,  肝発癌 ,  HCVTgM ,  鉄過剰状態 ,  鉄過剩状態 ,  トランスジェニックマウス ,  C型肝炎 ,  鉄代謝 ,  活性酸素 ,  C型肝炎ウイルス ,  EBP ,  肝脂肪化 ,  CCAAT enhancer binding protein ,  C ,  CHOP ,  hepcidin ,  ヘプシジン ,  肝細胞癌 ,  鉄 ,  SREBP1 ,  鉄過剰 ,  グリチルリチン
Research theme for competitive and other funds  (8):
  • 2016 - 2019 Association between host factor and hepatocellular carcinoma in non-viral patients with type 2 diabetes
  • 2014 - 2017 Investigation of anti-angiogenesis therapy against hepatocellular carcinoma targeting liver-infiltrating myeloid cells.
  • 2013 - 2016 The mechanism of mitochondrial injury and iron overload induced hepatocarcinogenesis in the post hepatic virus.
  • 2011 - 2014 Analysis of hepatocarcinogenesis based on gender and mitochondrial biogenesis
  • 2010 - 2012 Association of between HCV induced mitochondria dysfunction and viral response by interferon in hepatic iron overloaded
Show all
Papers (90):
  • Kazutaka Terahara, Tian-Cheng Li, Keiji Matsubayashi, Hidekatsu Sakata, Takanobu Kato, Atsushi Naganuma, Koji Ogawa, Koichi Honda, Jun Itakura, Noriyuki Akutsu, et al. Calibrating Hepatitis E Virus Serological Assays Using Asymptomatic Specimens Obtained in Japan. Microbiology spectrum. 2022. 10. 5. e0214622
  • Masaaki Korenaga, Tatsuya Kanto. Testing, diagnosis of viral hepatitis, and the follow-up policy in Japan. Global health & medicine. 2021. 3. 5. 308-313
  • Jun Itakura, Masayuki Kurosaki, Hiroko Setoyama, Tetsuro Simakami, Noriko Oza, Masaaki Korenaga, Motohiko Tanaka, Takuji Torimura, Naoya Sakamoto, Nobuyuki Enomoto, et al. Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis. Journal of gastroenterology. 2021. 56. 5. 470-478
  • Yosuke Osawa, Sachiyo Yoshio, Yoshihiko Aoki, Masaaki Korenaga, Masatoshi Imamura, Takashi Oide, Miku Okawara, Hironari Kawai, Yuriko Tsutsui, Yuichi Yoshida, et al. Blood angiopoietin-2 predicts liver angiogenesis and fibrosis in hepatitis C patients. BMC gastroenterology. 2021. 21. 1. 55-55
  • 榎本 大, 日高 勲, 井上 泰輔, 磯田 広史, 井出 達也, 荒生 祥尚, 内田 義人, 井上 貴子, 池上 正, 柿崎 暁, et al. 肝疾患診療連携拠点病院における肝炎医療コーディネーターの現状. 肝臓. 2021. 62. 2. 96-98
more...
MISC (46):
  • Masaaki Korenaga, Namiki Izumi, Nobuharu Tamaki, Osamu Yokosuka, Tatsuo Kanda, Tetsuo Takehara, Naoya Sakamoto, Goki Suda, Shuhei Nishiguchi, Hirayuiki Enomoto, et al. MULTI-CENTER AND PROSPECTIVE COHORT STUDY OF 599 JAPANESE PATIENTS WITH HCV GENOTYPE 1 INFECTION REVEALS SUSTAINED VIROLOGICAL RESPONSE BY LEDIPASVIR/SOFOSBUVIR REDUCES THE INCIDENCE OF HEPATOCELLULAR CARCINOMA AS SAME AS PEG-INTERFERON PLUS RIBAVIRIN. HEPATOLOGY. 2019. 70. 368A-369A
  • 是永 匡紹, 榎本 大, 是永 圭子, 横須賀 收, 井出 達也, 井上 貴子, 日高 勲, 柿崎 暁, 小林 良正, 本田 浩一, et al. DAA治療予後と残された課題 SVR後発がんとHCV陽性者の撲滅. 肝臓. 2019. 60. Suppl.1. A386-A386
  • Masaaki Korenaga, Namiki Izumi, Nobuharu Tamaki, Osamu Yokosuka, Tetsuo Takehara, Naoya Sakamoto, Goki Suda, Shuhei Nishiguchi, Hirayuki Enomoto, Fusao Ikeda, et al. The Risk of Hepatocellular Carcinoma Development after Sustained Virologic Response Are Similar between Japanese Patients with HCV Genotype 1 Infection Treated with Ledipasvir/Sofosbuvir and Protease Inhibitor with Peg-Interferon Plus Ribavirin. HEPATOLOGY. 2018. 68. 535A-536A
  • Yu Noda, Takumi Kawaguchi, Masaaki Korenaga, Sachiyo Yoshio, Sho Komukai, Masahito Nakano, Takashi Niizeki, Hironori Koga, Atsushi Kawaguchi, Tatsuya Kanto, et al. A Prognostic Impact of an Activator of Tumor-Associated Macrophages, Interleukin-34, in Patients with Non-Viral Hepatocellular Carcinoma: A Data-Mining Analysis. HEPATOLOGY. 2018. 68. 844A-844A
  • 由雄 祥代, 河合 裕成, 坂本 譲, 島垣 智成, 青木 孝彦, 土肥 弘義, 大澤 陽介, 是永 匡紹, 考藤 達哉. CXCL13/IL-21誘導はB型急性・慢性肝炎患者のHBs抗原陰性化に寄与する. 肝臓. 2018. 59. Suppl.2. A658-A658
more...
Work history (2):
  • 2014 - 現在 国立研究開発法人 国立国際医療研究センター
  • 2012 - 2013 National Center for Global Health and Medicine
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page